Abstract
Severe hypercalcemia associated with vitamin D intoxication or malignancy in children is a rare and life-threatening condition. There is little published experience with Zoledronic acid (ZA) in the treatment of pediatric severe hypercalcemia. Here, we present two pediatric cases of severe hypercalcemia, one due to vitamin D intoxication and the second to malignancy, in which ZA was used as the first-line bisphosphonate in the treatment. While both cases responded well to a single dose of ZA, the second case experienced hypocalcemia requiring calcium treatment after ZA infusion. Our report shows that ZA may be an effective option in the treatment of severe pediatric hypercalcemia, although patients should be followed closely after infusion due to the risk of hypocalcemia. We provide additional published evidence for the effectiveness of ZA in correcting severe pediatric hypercalcemia and hope this will encourage future studies with larger numbers of patients.
Keywords: Hypercalcemia of malignancy, hypocalcemia, pamidronate, vitamin D intoxication, zoledronic acid
Read the full text
3 sections · 3 figures · 1 table · PDF
Create your free account to read the full text.
- Full text with figures and tables
- PDF and supplementary files
- Access on every Galenos journal
One Galenos account works on every Galenos journal site.
References
Stokes VJ, Nielsen MF, Hannan FM, Thakker RV. Hypercalcemic Disorders in Children. J Bone Miner Res 2017;32:2157-2170. Epub 2017 Nov 2
Davies JH, Shaw NJ. Investigation and management of hypercalcaemia in children. Arch Dis Child 2012;97:533-558. Epub 2012 Mar 23
Jones G. Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr 2008;88:582-586.
Demir K, Döneray H, Kara C, Atay Z, Çetinkaya S, Çayır A, Anık A, Eren E, Uçaktürk A, Can Yılmaz G, Törel Ergür A, Kendirci M, Aycan Z, Bereket A, Aydın M, Orbak Z, Özkan B. Comparison of Treatment Regimens in Management of Severe Hypercalcemia Due to Vitamin D Intoxication in Children. J Clin Res Pediatr Endocrinol 2019;11:140-148. Epub 2018 Nov 5
Kerdudo C, Aerts I, Fattet S, Chevret L, Pacquement H, Doz F, Michon J, Garabedian M, Orbach D. Hypercalcemia and childhood cancer: a 7-year experience. J Pediatr Hematol Oncol 2005;27:23-27.
Major P, Lortholary A, Hon J, Abdi E, Mills G, Menssen HD, Yunus F, Bell R, Body J, Quebe-Fehling E, Seaman J. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol 2001;19:558-567.
George S, Weber DR, Kaplan P, Hummel K, Monk HM, Levine MA. Short-Term Safety of Zoledronic Acid in Young Patients With Bone Disorders: An Extensive Institutional Experience. J Clin Endocrinol Metab 2015;100:4163-4171. Epub 2015 Aug 26
Bowden SA, Mahan JD. Zoledronic acid in pediatric metabolic bone disorders. Transl Pediatr 2017;6:256-268.
Nimesh M, Singh P, Jhamb U, Dubey AP. An Unsuspected Pharmacological Vitamin D Toxicity in a Child and its Brief Review of Literature. Toxicol Int 2015;22:167-169.
Hatun S, Cizmecioğlu F. Use of alendronate in the treatment of vitamin D intoxication in infants. Turk J Pediatr 2005;47:373-375.
Park HJ, Choi EJ, Kim JK. A successful treatment of hypercalcemia with zoledronic acid in a 15-year-old boy with acute lymphoblastic leukemia. Ann Pediatr Endocrinol Metab 2016;21:99-104. Epub 2016 Jun 30
Kolyva S, Efthymiadou A, Gkentzi D, Karana-Ginopoulou A, Varvarigou A. Hypercalcemia and osteolytic lesions as presenting symptoms of acute lymphoblastic leukemia in childhood. The use of zoledronic acid and review of the literature. J Pediatr Endocrinol Metab 2014;27:349-354.
Bota M, Popa G, Neaga A, Gocan H, Blag CL. Acute Lymphoblastic Leukemia with Malignant Hypercalcemia: A Case Report. Am J Case Rep 2019;20:402-405.
Martins AL, Moniz M, Nunes PS, Abadesso C, Loureiro HC, Duarte X, Almeida HI. Severe hypercalcemia as a form of acute lymphoblastic leukemia presentation in children. Rev Bras Ter Intensiva 2015;27:402-405.
Colak U, Mutlu GY, Sozmen BO, Yucel EB, Kayserili H, Hatun S. Zoledronate-responsive calcitriol-mediated hypercalcemia in a 5-year-old case with squamous cell carcinoma on the background of xeroderma pigmentosum. J Pediatr Endocrinol Metab 2019;32:1403-1406.


